• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

  • There's just no denying
    good chemistry

    Explore the PRA HEALTH SCIENCES interactive experience to find out what makes us tick.

Social Media

See the latest interactions from our social media


We'll be attending a number of conferences this week, some of our Early Development Services staff will...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences, Inc. Reports 4th Quarter and Full Year 2014 Results and 2015 Guidance

• $323.8 million of service revenue in the fourth quarter; 8% consolidated service revenue growth compared to the fourth quarter of 2013.

• $50.6 million of Adjusted EBITDA in the...

PRA Health Sciences Announces Appointment of New Director

9 February, 2015, Raleigh, N.C. – PRA Health Sciences, Inc. (NASDAQ: PRAH) today announced the appointment of Matthew P. Young to the Board of Directors of the Company. As a member of the...

PRA Health Sciences to Report Fourth Quarter 2014 Earnings

4 February, 2015, Raleigh, N.C. – PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and year end 2014 results after the market closes on Wednesday, February 18,...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter


PRA Health Sciences (PRA) provides innovative drug development solutions across all phases and therapeutic areas. But innovation just for the sake of innovation isn’t why we do it

CAPABILITIES: Early Phase Pain Studies

In our Early Development Services (EDS) group, we have state-of-the-art Phase I facilities and equipment combined with a broad expertise in pain studies and availability of a large network of pain specialists

FACT SHEET: Rare Diseases

Clinical development involving rare diseases poses a unique set of medical, scientific, and operational challenges. PRA understands these challenges and the critical success factors necessary to develop drugs for rare disease patients


Find out what's happening next on PRA's event schedule

March 3 - March 7

The American Society for Clinical Pharmacology and Therapeutics (ASCPT) was founded in 1900, and consists of over 2,100 professionals committed to promoting and advancing the science and practice of human pharmacology and therapeutics for the benefit of patients and society. The Society is the largest scientific and professional organization serving the discipline of clinical pharmacology. […]

March 4 - March 5

Our story started in 2012, when the event launched as a sister conference alongside the World Generic Medicines Congress. The topic of biosimilars had been debated and discussed for many years within the generics event, but as the commercial, political and scientific drivers continued to pick up pace, we provided a much needed platform to […]

March 5 - March 7

“The Best of ESHRE & ASRM” is a Continuing Medical Education (CME) program intended to assess the evidence for both established and emerging approaches to the science and art of reproductive healthcare. Faculty from the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine will compare and contrast global procedures […]

Read More >